Impact of a multidisciplinary endocarditis evaluation team for opioid use associated infective endocarditis
Journal of Hospital Medicine · 28.07.2026
DOI: 10.1002/jhm.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Medicine, online erschienen am 28.07.2026. Verfasst von Melissa B Weimer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yale School of Medicine, Program in Addiction Medicine, Section of General Internal Medicine, New Haven, Connecticut, USA. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Infective endocarditis (IE) related to opioid use disorder (OUD) and injection substance use is on the rise. Multidisciplinary care is recommended for individuals with substance‐related IE, but little is known about the impact of this care.
Objectives
A retrospective cohort study to evaluate the impact of a multidisciplinary endocarditis evaluation team (MEET) on outcomes for patients with IE and specifically OUD‐related IE. The MEET is a clinical team from multiple specialities that collaboratively facilitates optimal hospital‐based treatment, including addiction‐related treatment.
Methods
The study compares a historical control group of hospitalized adults with OUD and OUD‐related IE who did not receive the MEET intervention (treatment as usual [TAU] group) with a group of hospitalized adults with OUD and OUD‐related IE who received the MEET intervention. The primary outcome is receipt of medication for OUD (MOUD) at hospital discharge. Secondary outcomes are receipt of OUD treatment referral, 30‐day ED visits, 30‐day hospital re‐admission, all‐cause mortality, recurrence of IE, and repeat IE‐related surgery.
Results
Nearly all patients in the MEET group ( n = 68) were discharged on MOUD compared with the TAU group ( n = 58) (98.5% vs. 56.9%) and received a referral for OUD treatment (97.1% vs. 74.1%). We were unable to detect a difference in 30‐day ED visits and hospital readmissions, all‐cause mortality, recurrent IE, and repeat IE‐related surgery.
Conclusions
A multidisciplinary intervention was associated with improved OUD‐related outcomes. No change was observed in health care utilization, all‐cause mortality, or other IE‐related outcomes.
Autor:innen und Institutionen
- Department of Medicine, Yale School of Medicine, Program in Addiction Medicine, Section of General Internal Medicine, New Haven, Connecticut, USA.
- Department of Chronic Disease Epidemiology, School of Public Health, New Haven, Connecticut, USA.
- Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
- Division of Cardiac Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Medicine, Yale School of Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.
- Department of Medicine, Yale School of Medicine, Section of Cardiovascular Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Melissa B Weimer
Zitieren
APA
Weimer, M. B., Wang, K., Degife, E., Wells, N., Golden, M., Hull, S. C., Vallabhajosyula, P., & Geirsson, A. (2026). Impact of a multidisciplinary endocarditis evaluation team for opioid use associated infective endocarditis. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.70412
Vancouver
Weimer MB, Wang K, Degife E, Wells N, Golden M, Hull SC, et al. Impact of a multidisciplinary endocarditis evaluation team for opioid use associated infective endocarditis. Journal of Hospital Medicine. 2026. doi:10.1002/jhm.70412
BibTeX
@article{Weimer2026,
author = {Weimer, Melissa B and Wang, Kaicheng and Degife, Ellelan and Wells, Nicholas and Golden, Marjorie and Hull, Sarah C and Vallabhajosyula, Prashanth and Geirsson, Arnar},
title = {Impact of a multidisciplinary endocarditis evaluation team for opioid use associated infective endocarditis},
journal = {Journal of Hospital Medicine},
year = {2026},
doi = {10.1002/jhm.70412}
}
EUVIMED